Cite
HARVARD Citation
Chéret, A. et al. (n.d.). Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial. Lancet infectious diseases. 15 (4), pp. 387-396. [Online].